Survival benefit of transarterial chemoembolization in patients with metastatic hepatocellular carcinoma: a single center experience

BACKGROUND: As prognosis of patients with metastatic hepatocellular carcinoma (HCC) is mainly determined by intrahepatic HCC progression, local treatment with TACE may result in improved OS, although it is not recommended. The purpose of this study was to analyze retrospectively the efficacy of TACE...

Descripción completa

Detalles Bibliográficos
Autores principales: Bettinger, Dominik, Spode, Renan, Glaser, Nicolas, Buettner, Nico, Boettler, Tobias, Neumann-Haefelin, Christoph, Brunner, Thomas Baptist, Gkika, Eleni, Maruschke, Lars, Thimme, Robert, Schultheiss, Michael
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2017
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553671/
https://www.ncbi.nlm.nih.gov/pubmed/28797231
http://dx.doi.org/10.1186/s12876-017-0656-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5553671/
https://www.ncbi.nlm.nih.gov/pubmed/28797231
http://dx.doi.org/10.1186/s12876-017-0656-z

Ejemplares similares